FIJYX vs. SHPAX
Compare and contrast key facts about Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and Saratoga Health & Biotechnology Fund (SHPAX).
FIJYX is managed by Fidelity. It was launched on Oct 2, 2018. SHPAX is managed by Saratoga. It was launched on Jul 14, 1999.
Performance
FIJYX vs. SHPAX - Performance Comparison
Loading graphics...
FIJYX vs. SHPAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 2.35% | 40.09% | 0.03% | 11.19% | -7.60% | -2.76% | 32.72% | 26.25% | -11.45% |
SHPAX Saratoga Health & Biotechnology Fund | 0.66% | 17.43% | 0.26% | -0.36% | 1.93% | 16.71% | 3.52% | 27.67% | -11.64% |
Returns By Period
In the year-to-date period, FIJYX achieves a 2.35% return, which is significantly higher than SHPAX's 0.66% return.
FIJYX
- 1D
- 5.06%
- 1M
- -0.73%
- YTD
- 2.35%
- 6M
- 15.76%
- 1Y
- 55.98%
- 3Y*
- 18.69%
- 5Y*
- 8.12%
- 10Y*
- —
SHPAX
- 1D
- 1.81%
- 1M
- -5.10%
- YTD
- 0.66%
- 6M
- 9.79%
- 1Y
- 15.26%
- 3Y*
- 7.57%
- 5Y*
- 5.93%
- 10Y*
- 7.03%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
FIJYX vs. SHPAX - Expense Ratio Comparison
FIJYX has a 0.61% expense ratio, which is lower than SHPAX's 2.90% expense ratio.
Return for Risk
FIJYX vs. SHPAX — Risk / Return Rank
FIJYX
SHPAX
FIJYX vs. SHPAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Fidelity Advisor Biotechnology Fund Class Z (FIJYX) and Saratoga Health & Biotechnology Fund (SHPAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FIJYX | SHPAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.96 | 0.86 | +1.10 |
Sortino ratioReturn per unit of downside risk | 2.56 | 1.28 | +1.27 |
Omega ratioGain probability vs. loss probability | 1.33 | 1.16 | +0.17 |
Calmar ratioReturn relative to maximum drawdown | 3.20 | 1.89 | +1.31 |
Martin ratioReturn relative to average drawdown | 12.85 | 5.16 | +7.68 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| FIJYX | SHPAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.96 | 0.86 | +1.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.35 | 0.42 | -0.07 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.43 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.43 | 0.30 | +0.12 |
Correlation
The correlation between FIJYX and SHPAX is 0.66, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
FIJYX vs. SHPAX - Dividend Comparison
FIJYX's dividend yield for the trailing twelve months is around 1.41%, less than SHPAX's 3.64% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
FIJYX Fidelity Advisor Biotechnology Fund Class Z | 1.41% | 1.44% | 0.00% | 1.55% | 0.00% | 18.90% | 8.13% | 6.49% | 2.35% | 0.00% | 0.00% | 0.00% |
SHPAX Saratoga Health & Biotechnology Fund | 3.64% | 3.66% | 1.35% | 5.38% | 6.34% | 3.76% | 13.82% | 13.24% | 22.00% | 17.98% | 12.52% | 10.70% |
Drawdowns
FIJYX vs. SHPAX - Drawdown Comparison
The maximum FIJYX drawdown since its inception was -38.53%, smaller than the maximum SHPAX drawdown of -69.50%. Use the drawdown chart below to compare losses from any high point for FIJYX and SHPAX.
Loading graphics...
Drawdown Indicators
| FIJYX | SHPAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -38.53% | -69.50% | +30.97% |
Max Drawdown (1Y)Largest decline over 1 year | -13.59% | -7.87% | -5.72% |
Max Drawdown (5Y)Largest decline over 5 years | -36.39% | -16.32% | -20.07% |
Max Drawdown (10Y)Largest decline over 10 years | — | -28.05% | — |
Current DrawdownCurrent decline from peak | -2.49% | -5.31% | +2.82% |
Average DrawdownAverage peak-to-trough decline | -11.76% | -28.07% | +16.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.69% | 2.88% | +0.81% |
Volatility
FIJYX vs. SHPAX - Volatility Comparison
Fidelity Advisor Biotechnology Fund Class Z (FIJYX) has a higher volatility of 9.34% compared to Saratoga Health & Biotechnology Fund (SHPAX) at 5.09%. This indicates that FIJYX's price experiences larger fluctuations and is considered to be riskier than SHPAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| FIJYX | SHPAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.34% | 5.09% | +4.25% |
Volatility (6M)Calculated over the trailing 6-month period | 17.01% | 9.90% | +7.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.00% | 16.63% | +9.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.43% | 14.21% | +9.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.07% | 16.57% | +8.50% |